Consider participating in our Hypothyroidism research study for people aged 18-75 years. The study may be suitable for you if you have been taking daily Levothyroxine. Oher criteria apply. You may be compensated for your participation in the study.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17.
Accellacare is enrolling a research study evaluating an investigational medication for pain associated with post-surgical neuropathy. Eligible participants will receive study-related care and study medication at no cost.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare has multiple options available to participate in migraine trials.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17.
This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.
Accellacare is enrolling adults for a vaccine research study. Eligible participants will receive study-related care and study vaccine at no cost. Financial compensation will also be provided for time and travel expenses.
Accellacare provides options for health adults over 18 to be a part of medical advancements. Eligible participants will receive study-related care and financial compensation for time and travel.
Accellacare provides options for health adults over 18 to be a part of medical advancements. Eligible participants will receive study-related care and financial compensation for time and travel.
Learn more about research opportunities in dermatology. Currently, Accellacare is looking for patients who are interested to participate in studies for a variety of skin conditions and ailments. Eligible participants will receive financial compensation and study related care at no cost. Refer an eligible friend to receive $50.
By getting a vaccine, you could also support research.
Adults 18 years or older (medically stable).
Other criteria apply.
All eligible participants will receive a seasonal illness vaccine, study-related care at no cost, and financial compensation for time and travel expenses.
Accellacare is enrolling volunteers to evaluate an investigational medication for type 2 diabetes. Eligible volunteers will receive study-related care and medication at no cost. Financial compensation will also be provided for time and travel expenses.
NASH, short for Nonalcoholic Steatohepatitis, is an advanced nonalcoholic fatty liver disease characterized by a buildup of fat on the liver that can cause permanent damage hindering its ability to filter the blood.
Accellacare saw a need for a patient feedback and engagement program that gives patients a voice directly to the industry, to help create a truly patient-centric clinical research environment. The answer was The Patient Voice program.
Know someone who may benefit from research participation? Provide your referrals* below and we will contact them about their volunteer options. If they qualify, you will receive a gift card as a thank you.
Every year on February 4th, the world unites to observe World Cancer Day, a global initiative dedicated to raising awareness, promoting prevention, and advocating for better treatment and care.
February is dedicated to raising awareness about pediatric heart disease and recognizing the strength of cardiac patients, their families, and caregivers.